Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dried blood spot monitoring for vancomycin and creatinine in OPAT
NL-OMON53282Recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2023
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of vancomycin in bacterial disease (2 arms), sponsored by Erasmus MC. Primary endpoint: Amount of outpatient visits regarding vancomycin therapy. Started Nov 2023; status: recruiting.
02
Drugs
vancomycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON53282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53282.